These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 7812980)
1. Correlation between family history of colorectal cancer and pathological and clinical features of the disease. Aste H; Picasso M; Allegretti A; Conio M Cancer Detect Prev; 1994; 18(5):343-8. PubMed ID: 7812980 [TBL] [Abstract][Full Text] [Related]
2. [Colorectal adenocarcinoma in patients with familial anamnesis positive for malignant neoplasms of the large intestine]. Aste H; Picasso M; Allegretti A; Conio M Epidemiol Prev; 1992 Jun; 14(51):25-9. PubMed ID: 1345012 [TBL] [Abstract][Full Text] [Related]
3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694 [TBL] [Abstract][Full Text] [Related]
5. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929 [TBL] [Abstract][Full Text] [Related]
6. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease. Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293 [TBL] [Abstract][Full Text] [Related]
7. [Multivariate analysis of prognostic factors in colorectal cancer patients with different ages]. Cai SR; Zheng S; Zhang SZ Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):483-5. PubMed ID: 16188146 [TBL] [Abstract][Full Text] [Related]
8. Young age is not a poor prognostic marker in colorectal cancer. Chung YF; Eu KW; Machin D; Ho JM; Nyam DC; Leong AF; Ho YH; Seow-Choen F Br J Surg; 1998 Sep; 85(9):1255-9. PubMed ID: 9752871 [TBL] [Abstract][Full Text] [Related]
9. Risk of colorectal cancer in relatives: a case control study. Safaee A; Moghimi-Dehkordi B; Pourhoseingholi MA; Vahedi M; Maserat E; Ghiasi S; Fatemi SR; Zali MR Indian J Cancer; 2010; 47(1):27-30. PubMed ID: 20071786 [TBL] [Abstract][Full Text] [Related]
10. A scoring system for the strength of a family history of colorectal cancer. Church JM Dis Colon Rectum; 2005 May; 48(5):889-96. PubMed ID: 15785893 [TBL] [Abstract][Full Text] [Related]
11. [Screening practices and familial antecedents of colorectal cancer. Survey with a voluntary population]. Eisinger F; Giordanella JP; Didelot R; Julian-Reynier C; Moatti JP; Sobol H; Seitz JF Gastroenterol Clin Biol; 1996; 20(8-9):627-32. PubMed ID: 8977808 [TBL] [Abstract][Full Text] [Related]
12. Different distribution of Dukes' stage between proximal and distal colorectal cancer. Ikeda Y; Akagi K; Kinoshita J; Abe T; Miyazaki M; Mori M; Sugimachi K Hepatogastroenterology; 2002; 49(48):1535-7. PubMed ID: 12397728 [TBL] [Abstract][Full Text] [Related]
13. A retrospective study of colorectal cancer patients in King Chulalongkorn Memorial Hospital. Kullavanijaya P; Rerknimitr R; Amornrattanakosol J J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S85-90. PubMed ID: 12188457 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival. Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528 [TBL] [Abstract][Full Text] [Related]
15. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up. Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236 [TBL] [Abstract][Full Text] [Related]
16. Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome. Skelly MM; Troy A; Duffy MJ; Mulcahy HE; Duggan C; Connell TG; O'Donoghue DP; Sheahan K Clin Cancer Res; 1997 Oct; 3(10):1837-40. PubMed ID: 9815571 [TBL] [Abstract][Full Text] [Related]
17. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Purdie CA; Piris J Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056 [TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity of TP53 is not correlated with clinicopathological variables in sporadic colorectal carcinomas. González-Aguilera JJ; Herrero MP; Maillo C; Moreno-Azcoita M; Fernández-Peralta AM Anticancer Res; 1999; 19(2A):1325-9. PubMed ID: 10368694 [TBL] [Abstract][Full Text] [Related]
19. Mismatch repair protein MSH2, cytokeratin 18 and cytokeratin 20 expression: clinicopathological correlation and prognostic value in colorectal cancer patients. González JJ; Bernardo CG; Sanz L; Fresno MF; Barbón E; Noval JG; Martínez E Hepatogastroenterology; 2007 Dec; 54(80):2266-71. PubMed ID: 18265645 [TBL] [Abstract][Full Text] [Related]
20. The cytogenetic identification of high risk members in colorectal cancer families. Jyothish B; Ankathil R; Chandini R; Vinodkumar B; Nayar GS; Roy DD; Madhavan J; Nair MK Neoplasma; 1997; 44(4):258-62. PubMed ID: 9473780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]